Cargando…

Survey of practices for the clinical management of febrile neutropenia in children in hematology-oncology units in Latin America

The management of febrile neutropenia (FN) in pediatrics is evolving. Our objective was to describe current practices for the care of patients with FN in pediatric oncology centers in Latin America and identify areas for practice improvement. We used an online survey to enroll eligible healthcare pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melgar, Mario A., Homsi, Maysam R., Happ, Brooke, Su, Yin, Tang, Li, Gonzalez, Miriam L., Caniza, Miguela A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550596/ https://www.ncbi.nlm.nih.gov/pubmed/34189607 http://dx.doi.org/10.1007/s00520-021-06381-9

Ejemplares similares

Guidance Statement for the Management of Febrile Neutropenia in Pediatric Patients Receiving Cancer-Directed Therapy in Central America and the Caribbean
por: Melgar, Mario, et al.
Publicado: (2020)

The PRINCIPAL Network: A Model to Optimize Infection Care and Prevention in Pediatric Oncology in the Latin American Region
por: Caniza, Miguela A., et al.
Publicado: (2022)

High morbidity and mortality associated with primary bloodstream infections among pediatric patients with cancer at a Guatemalan tertiary referral hospital
por: Mukkada, Sheena, et al.
Publicado: (2022)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia
por: Cerasi, Sara, et al.
Publicado: (2023)

Development, Implementation, and Outcomes of a Global Infectious Disease Training Course
por: Caniza, Miguela A, et al.
Publicado: (2021)

The Golden Hour: Sustainability and Clinical Outcomes of Adequate Time to Antibiotic Administration in Children with Cancer and Febrile Neutropenia in Northwestern Mexico
por: Gonzalez, Miriam L., et al.
Publicado: (2021)

Update on the management of febrile neutropenia in hematologic patients
por: Escrihuela-Vidal, Francesc, et al.
Publicado: (2019)

Diagnostic Radiology in Hematological Patients with Febrile Neutropenia
por: Heussel, Claus Peter
Publicado: (2014)

Author Correction: The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia
por: Cerasi, Sara, et al.
Publicado: (2023)

Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
por: Monuszko, Karen A., et al.
Publicado: (2021)

A questionnaire survey on evaluation for penetration and compliance of the Japanese Guideline on Febrile Neutropenia among hematology-oncology physicians and surgeons
por: Akiyama, Nobu, et al.
Publicado: (2021)

Outcomes of Care-bundle Implementation for Children With Cancer and Suspected Bloodstream Infection in a Pediatric Oncology Unit in a Resource-limited Setting
por: Escobedo-Melendez, Griselda, et al.
Publicado: (2023)

Epidemiology of acute febrile illness in Latin America
por: Moreira, J., et al.
Publicado: (2018)

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
por: Demirel, Aslıhan, et al.
Publicado: (2015)

Interventions for enhancing an online infection control course for Latin American countries
por: Gonzalez, M, et al.
Publicado: (2015)

Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia
por: Teofili, Luciana, et al.
Publicado: (2016)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
por: Álvarez, José C., et al.
Publicado: (2021)

Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
por: Cennamo, Federica, et al.
Publicado: (2021)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Hematology in Latin America: where are we? Analysis of the reports of Societies of Hematology associated organization of the Highlights of ASH in Latin America
por: Gabús, Raul, et al.
Publicado: (2011)

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2014)

Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics
por: Lappalainen, Marika, et al.
Publicado: (2018)

The Pattern of Microorganisms and Drug Susceptibility in Pediatric Oncologic Patients with Febrile Neutropenia
por: Jungrungrueng, Thanyathorn, et al.
Publicado: (2021)

Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
por: Álvarez, José C, et al.
Publicado: (2013)

Coronaviruses in children with febrile neutropenia
por: Alvares, Paula A., et al.
Publicado: (2013)

Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients
por: Lakshmaiah, Kuntegowdanahalli C, et al.
Publicado: (2015)

Corrigendum to “Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update”
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2019)

Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia
por: Korpelainen, Sini, et al.
Publicado: (2017)

Remote Monitoring of Patients With Hematologic Malignancies at High Risk of Febrile Neutropenia: Exploratory Study
por: Kroloff, Maxwell, et al.
Publicado: (2022)

Chemotherapy Induced Neutropenia, Febrile-Neutropenia and Determinants Among Solid Cancer Patients Attending Oncology Unit of a Tertiary Care Teaching Hospital in Ethiopia
por: Dessalegn, Mekonnen, et al.
Publicado: (2023)

Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia
por: Hodgson-Viden, Heather, et al.
Publicado: (2005)

Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia
por: Thangthong, Jutarat, et al.
Publicado: (2020)

Diagnosis and Management of Febrile Neutropenia in Pediatric Oncology Patients—A Systematic Review
por: Boeriu, Estera, et al.
Publicado: (2022)

All-Cause Mortality and Its Predictors in Haemato-Oncology Patients with Febrile Neutropenia
por: Shmuely, Haim, et al.
Publicado: (2023)

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Febrile Neutropenia in Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2018)

Febrile Neutropenia in Children with Cancer
por: Paulus, Stéphane, et al.
Publicado: (2008)

Outpatient management of febrile neutropenia in children with cancer
por: Ziino, Ottavio, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_s665fhmq32m4mln29kepciqj6p